Compile Data Set for Download or QSAR
maximum 50k data
Found 639 with Last Name = 'pizzirani' and Initial = 'd'
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50007674((+)-erythro 4-[2-(4-Benzyl-piperidin-1-yl)-1-hydro...)
Affinity DataKi:  29nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398926(CHEMBL2178786)
Affinity DataKi:  2.90E+3nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398918(CHEMBL2178778)
Affinity DataKi:  3.32E+3nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398928(CHEMBL2178784)
Affinity DataKi:  4.60E+3nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398924(CHEMBL2178788)
Affinity DataKi:  5.25E+3nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398915(CHEMBL2178781)
Affinity DataKi:  9.76E+3nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398927(CHEMBL2178785)
Affinity DataKi:  1.10E+4nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398929(CHEMBL2178783)
Affinity DataKi:  4.09E+4nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398922(CHEMBL2178790)
Affinity DataKi: >1.00E+5nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398923(CHEMBL2178789)
Affinity DataKi: >1.00E+5nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398917(CHEMBL2178779)
Affinity DataKi: >1.00E+5nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398925(CHEMBL2178787)
Affinity DataKi: >1.00E+5nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398916(CHEMBL2178780)
Affinity DataKi: >1.00E+5nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398919(CHEMBL2178777)
Affinity DataKi: >1.00E+5nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398920(CHEMBL2178776)
Affinity DataKi: >1.00E+5nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398921(CHEMBL2178791)
Affinity DataKi: >1.00E+5nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398930(CHEMBL2178782)
Affinity DataKi: >1.00E+5nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50062599(3,5-Dimethyl-adamantan-1-ylamine | CHEMBL807 | EN3...)
Affinity DataKi: >1.00E+5nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM10404((1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetrac...)
Affinity DataKi: >1.00E+5nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50030386((1S)-1-methyl-16-azatetracyclo[7.6.1.0^{2,7}.0^{10...)
Affinity DataKi: >1.00E+5nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
TargetAcid ceramidase(Homo sapiens (Human))
Fondazione Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM29080(CHEMBL280065 | N-oleoylethanolamine | Oleamide MEA...)
Affinity DataKi:  5.00E+5nMAssay Description:Inhibition of acid ceramidase (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium-dependent serotonin transporter(Rattus norvegicus (rat))
Universit£

Curated by ChEMBL
LigandPNGBDBM50084717((+)-(1R,2R,3S,5S)-methyl 3-(benzoyloxy)-8-methyl-8...)
Affinity DataIC50:  0.5nMAssay Description:Displacement of [3H]paroxetine from Serotonin transporter of rat caudate putamenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Rattus norvegicus (rat))
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398922(CHEMBL2178790)
Affinity DataIC50:  0.520nMAssay Description:Inhibition of AChE in Wistar rat brain homogenates using acetylthiocholine iodide and DTNB as substrate after 10 mins by Ellman methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcid ceramidase(Homo sapiens (Human))
Fondazione Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM367209(2-oxo-4-phenyl-N-(4- phenylbutyl)-1,3- benzoxazole...)
Affinity DataIC50:  0.800nMAssay Description:The assay was performed in Optiplate 96-wells black plates, with each reaction well containing a mixture of 25 mM sodium acetate buffer pH 4.5 and a ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcid ceramidase(Homo sapiens (Human))
Fondazione Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM367209(2-oxo-4-phenyl-N-(4- phenylbutyl)-1,3- benzoxazole...)
Affinity DataIC50:  0.800nMAssay Description:Inhibition of recombinant human acid ceramidase expressed in HEK293 cells using N-[(1S,2R)-2-hydroxy-1-(hydroxymethyl)-4-(2-oxochromen-7-yl)-oxybutyl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Chiesi Farmaceutici

US Patent
LigandPNGBDBM645496(US20240018122, Example 181)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Chiesi Farmaceutici

US Patent
LigandPNGBDBM645497(N-(4-((6-(5-chloro-2- fluorophenyl)-3- (trifluorom...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Chiesi Farmaceutici

US Patent
LigandPNGBDBM645498(N-(4-{[6-(5-chloro-2- fluorophenyl)-3- (trifluorom...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Chiesi Farmaceutici

US Patent
LigandPNGBDBM645499(N-(4-{[6-(5-chloro-2- fluorophenyl)-3- (trifluorom...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Chiesi Farmaceutici

US Patent
LigandPNGBDBM645500(N-(4-{[6-(5-chloro-2- fluorophenyl)-3- (trifluorom...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Chiesi Farmaceutici

US Patent
LigandPNGBDBM645501(US20240018122, Example 187 | methyl 3-[6-(5-chloro...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Chiesi Farmaceutici

US Patent
LigandPNGBDBM645502(US20240018122, Example 189 | methyl (1r,4r)-4-(6-(...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Chiesi Farmaceutici

US Patent
LigandPNGBDBM645503(N-[4-({6-[5-(difluoromethyl)- 2-fluorophenyl]-3- m...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Chiesi Farmaceutici

US Patent
LigandPNGBDBM645504(US20240018122, Example 191 | methyl 4-(6-(5-chloro...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Chiesi Farmaceutici

US Patent
LigandPNGBDBM645505(N-[6-(5-chloro-2-fluorophenyl)- pyridazin-4-yl]-7-...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Chiesi Farmaceutici

US Patent
LigandPNGBDBM645506(4-{[6-(5-chloro-2-fluorophen- yl)pyridazin-4-yl]am...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Chiesi Farmaceutici

US Patent
LigandPNGBDBM645507(2-(morpholin-4-yl)ethyl 4-{[6- (5-chloro-2-fluorop...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Chiesi Farmaceutici

US Patent
LigandPNGBDBM645550(4-{[6-(5-chloro-2-fluorophen- yl)-3-methylpyridazi...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Chiesi Farmaceutici

US Patent
LigandPNGBDBM645551(4-{[6-(5-chloro-2-fluorophen- yl)pyridazin-4-yl]am...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Chiesi Farmaceutici

US Patent
LigandPNGBDBM645552(4-{[6-(5-chloro-2-fluorophen- yl)pyridazin-4-yl]am...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Chiesi Farmaceutici

US Patent
LigandPNGBDBM645553(4-{[6-(5-chloro-2-fluorophen- yl)pyridazin-4-yl]am...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Chiesi Farmaceutici

US Patent
LigandPNGBDBM645554(4-{[6-(5-chloro-2-fluorophen- yl)pyridazin-4-yl]am...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Chiesi Farmaceutici

US Patent
LigandPNGBDBM645555(4-{[6-(5-chloro-2-fluorophen- yl)-3-methylpyridazi...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Chiesi Farmaceutici

US Patent
LigandPNGBDBM645556(4-{[6-(5-chloro-2-fluorophen- yl)-3-methylpyridazi...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Chiesi Farmaceutici

US Patent
LigandPNGBDBM645550(4-{[6-(5-chloro-2-fluorophen- yl)-3-methylpyridazi...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Chiesi Farmaceutici

US Patent
LigandPNGBDBM645550(4-{[6-(5-chloro-2-fluorophen- yl)-3-methylpyridazi...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Chiesi Farmaceutici

US Patent
LigandPNGBDBM645559(US20240018122, Example 165 | methyl 4-{[6-(5-chlor...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Chiesi Farmaceutici

US Patent
LigandPNGBDBM645560(US20240018122, Example 171 | methyl 4-{[6-(5-chlor...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Chiesi Farmaceutici

US Patent
LigandPNGBDBM645561(US20240018122, Example 177 | [6-(5-chloro-2-fluoro...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Chiesi Farmaceutici

US Patent
LigandPNGBDBM645562(N-[6-(5-chloro-2-fluorophenyl)- 3-(trifluoromethyl...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
Displayed 1 to 50 (of 639 total ) | Next | Last >>
Jump to: